The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Cyclic Nucleotide Phosphodiesterase Activity, Expression, and Targeting in Cells of the Cardiovascular System
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Baillie, G. S., Sood, A., McPhee, I., Gall, I., Perry, S. J., Lefkowitz, R. J., & Houslay, M. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262787199 · Cited by 360
RetractedEffect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
Packer, M., Carver, J. R., Rodeheffer, R. J., Ivanhoe, R. J., DiBianco, R., Zeldis, S. M., Hendrix, G. H., Bommer, W. J., Elkayam, U., Kukin, M. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252103 · Cited by 2,225
Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP
de Rooij, J., Zwartkruis, F. J. T., Verheijen, M. H. G., Cool, R. H., Nijman, S. M. B., Wittinghofer, A., & Bos, J. L. (1998) · Nature · doi:10.1038/24884 · Cited by 1,969
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
Beavo, J. A. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.4.725 · Cited by 1,767
A Family of cAMP-Binding Proteins That Directly Activate Rap1
Kawasaki, H., Springett, G. M., Mochizuki, N., Toki, S., Nakaya, M., Matsuda, M., Housman, D. E., & Graybiel, A. M. (1998) · Science · doi:10.1126/science.282.5397.2275 · Cited by 1,362
Guanylyl Cyclases and Signaling by Cyclic GMP
Lucas, K. A., Pitari, G. M., Kazerounian, S., Ruiz-Stewart, I., Park, J., Schulz, S., Chepenik, K. P., & Waldman, S. A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01457-1 · Cited by 1,224
Beavo, J. A., & Reifsnyder, D. H. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90066-h · Cited by 849
HOUSLAY, M. D., & ADAMS, D. R. (2003) · Biochemical Journal · doi:10.1042/bj20021698 · Cited by 763
Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions
Soderling, S. H., & Beavo, J. A. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)00073-3 · Cited by 736
Regulation and Role of Adenylyl Cyclase Isoforms
Hanoune, J., & Defer, N. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.145 · Cited by 691
Michelakis, E., Tymchak, W., Lien, D., Webster, L., Hashimoto, K., & Archer, S. (2002) · Circulation · doi:10.1161/01.cir.0000016641.12984.dc · Cited by 577
Cyclic nucleotide phosphodiesterases: Relating structure and function
Francis, S. H., Turko, I. V., & Corbin, J. D. (2000) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(00)65001-8 · Cited by 564
mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module
Dodge, K. L. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1921 · Cited by 507
Targeting of Cyclic AMP Degradation to β 2 -Adrenergic Receptors by β-Arrestins
Perry, S. J., Baillie, G. S., Kohout, T. A., McPhee, I., Magiera, M. M., Ang, K. L., Miller, W. E., McLean, A. J., Conti, M., Houslay, M. D., et al. (2002) · Science · doi:10.1126/science.1074683 · Cited by 506
Wallis, R. M., Corbin, J. D., Francis, S. H., & Ellis, P. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00042-9 · Cited by 504
Myocyte Death, Growth, and Regeneration in Cardiac Hypertrophy and Failure
Nadal-Ginard, B., Kajstura, J., Leri, A., & Anversa, P. (2003) · Circulation Research · doi:10.1161/01.res.0000053618.86362.df · Cited by 503
Cyclic AMP-specific PDE4 Phosphodiesterases as Critical Components of Cyclic AMP Signaling
Conti, M., Richter, W., Mehats, C., Livera, G., Park, J.-Y., & Jin, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r200029200 · Cited by 481
The Molecular Biology of Cyclic Nucleotide Phosphodiesterases
(1999) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60718-7 · Cited by 435
Maurice, D. H., & Haslam, R. J. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10974-7 · Cited by 351
Self-citationAKAP Mediated Signal Transduction
Michel, J. J. C., & Scott, J. D. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.083101.135801 · Cited by 342
Recent Progress in Understanding the Hormonal Regulation of Phosphodiesterases
Conti, M., Némoz, G., Sette, C., & Vicini, E. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-370 · Cited by 312
Juilfs, D. M., Fülle, H.-J., Zhao, A. Z., Houslay, M. D., Garbers, D. L., & Beavo, J. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3388 · Cited by 312
Houslay, M. D., Sullivan, M., & Bolger, G. B. (1998) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60128-3 · Cited by 290
A kinase anchor proteins and the intracellular targeting of signals carried by cyclic AMP.
Cs, R. (1994) · PubMed · Cited by 290
The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding
Martinez, S. E., Wu, A. Y., Glavas, N. A., Tang, X.-B., Turley, S., Hol, W. G. J., & Beavo, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192374899 · Cited by 286
de Nucci, G., Gryglewski, R. J., Warner, T. D., & Vane, J. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2334 · Cited by 267
Pharmacology of phosphodiesterase inhibitors
(2005) · Therapeutic Strategies in COPD · doi:10.1201/b14809-12 · Cited by 261
PHARMACOLOGY OF PHOSPHODIESTERASE‐5 INHIBITORS
Corbin, J., & Francis, S. (2002) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2002.tb11296.x · Cited by 260
Zhao, A. Z., Huan, J.-N., Gupta, S., Pal, R., & Sahu, A. (2002) · Nature Neuroscience · doi:10.1038/nn885 · Cited by 242
Leptin inhibits insulin secretion by activation of phosphodiesterase 3B.
Zhao, A. Z., Bornfeldt, K. E., & Beavo, J. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3920 · Cited by 236
PDE5 is converted to an activated state upon cGMP binding to the GAF A domain
Rybalkin, S. D. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg051 · Cited by 234
Regan, C. P., Adam, P. J., Madsen, C. S., & Owens, G. K. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10522 · Cited by 233
SENZAKI, H., SMITH, C. J., JUANG, G. J., ISODA, T., MAYER, S. P., OHLER, A., PAOLOCCI, N., TOMASELLI, G. F., HARE, J. M., & KASS, D. A. (2001) · The FASEB Journal · doi:10.1096/fj.00-0538com · Cited by 228
Loughney, K., Hill, T. R., Florio, V. A., Uher, L., Rosman, G. J., Wolda, S. L., A. Jones, B., Howard, M. L., McAllister-Lucas, L. M., Sonnenburg, W. K., et al. (1998) · Gene · doi:10.1016/s0378-1119(98)00303-5 · Cited by 218
Regulation and function of the cyclic nucleotide phosphodiesterase (PDE3) gene family
Shakur, Y., Holst, L. S., Landstrom, T. R., Movsesian, M., Degerman, E., & Manganiello, V. (2000) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(00)66031-2 · Cited by 211
Houslay, M. D., & Kolch, W. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23096-0 · Cited by 202
Kim, D., Rybalkin, S. D., Pi, X., Wang, Y., Zhang, C., Munzel, T., Beavo, J. A., Berk, B. C., & Yan, C. (2001) · Circulation · doi:10.1161/hc4401.098432 · Cited by 196
Phosphodiesterases and Cyclic Nucleotide Signaling in Endocrine Cells
Conti, M. (2000) · Molecular Endocrinology · doi:10.1210/me.14.9.1317 · Cited by 191
Verde, I., Vandecasteele, G., Lezoualc’h, F., et al. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702506 · Cited by 188
Role of phosphodiesterases in the regulation of endothelial permeability in vitro.
Suttorp, N., Weber, U., Welsch, T., & Schudt, C. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116346 · Cited by 186
Arruda-Olson, A. M., Mahoney, D. W., Nehra, A., Leckel, M., & Pellikka, P. A. (2002) · JAMA · doi:10.1001/jama.287.6.719 · Cited by 183
Molecular Diversity of Cyclic AMP Signalling
Antoni, F. A. (2000) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0193 · Cited by 176
Cyclic GMP regulation of the L‐type Ca2+ channel current in human atrial myocytes
Vandecasteele, G., Verde, I., Rücker‐Martin, C., Donzeau‐Gouge, P., & Fischmeister, R. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0329a.x · Cited by 174
Hansen, G., Jin, S.-L. C., Umetsu, D. T., & Conti, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6751 · Cited by 154
Isoforms of Cyclic Nucleotide Phosphodiesterase PDE3A in Cardiac Myocytes
Wechsler, J., Choi, Y. H., Krall, J., Ahmad, F., Manganiello, V. C., & Movsesian, M. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203647200 · Cited by 141
Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1)
Kakkar, R., Raju, R. V. S., & Sharma, R. K. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050364 · Cited by 137
Ammendola, A., Geiselhöringer, A., Hofmann, F. B., & Schlossmann, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101530200 · Cited by 136
Giembycz, M. A. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.7.1361 · Cited by 135
Novel GPCRs and their endogenous ligands: expanding the boundaries of physiology and pharmacology
Marchese, A., George, S. R., Kolakowski, L. F., Lynch, K. R., & O’Dowd, B. F. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01366-8 · Cited by 133
Lugnier, C., & Schini‐Kerth, V. B. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90650-a · Cited by 130
Thyberg, J. (1998) · PubMed · doi:10.14670/hh-13.871 · Cited by 130
Cyclic Nucleotide Phosphodiesterase 1C Promotes Human Arterial Smooth Muscle Cell Proliferation
Rybalkin, S. D., Rybalkina, I. G., Beavo, J. A., & Bornfeldt, K. (2002) · Circulation Research · doi:10.1161/hh0202.104108 · Cited by 123
Cyclic nucleotide-gated channels: an expanding new family of ion channels.
Yau, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3481 · Cited by 115
Han, P., Werber, J., Surana, M., Fleischer, N., & Michaeli, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22337 · Cited by 110
Schoeffter, P., Lugnier, C., Demesy-Waeldele, F., et al. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90465-5 · Cited by 106
Membrane Localization of Cyclic Nucleotide Phosphodiesterase 3 (PDE3)
Shakur, Y., Takeda, K., Kenan, Y., Yu, Z., Rena, G., Brandt, D., Houslay, M. D., Degerman, E., Ferrans, V. J., & Manganiello, V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001734200 · Cited by 103
cGMP Signaling through cAMP- and cGMP-Dependent Protein Kinases
Lincoln, T., Komalavilas, P., Boerth, N. J., MacMillan-Crow, L. A., & Cornwell, T. L. (1995) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61094-7 · Cited by 96
Palmer, D., Tsoi, K., & Maurice, D. H. (1998) · Circulation Research · doi:10.1161/01.res.82.8.852 · Cited by 94
Self-citationSynergistic actions of nitrovasodilators and isoprenaline on rat aortic smooth muscle
Maurice, D. H., Crankshaw, D., & Haslam, R. J. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90048-u · Cited by 85
Self-citationSadhu, K., Hensley, K. M., Florio, V., & Wolda, S. L. (1999) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549904700707 · Cited by 80
Souness, J. E., Hassall, G. A., & Parrott, D. P. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90116-z · Cited by 77
Nitroprusside enhances isoprenaline-induced increases in cAMP in rat aortic smooth muscle
Maurice, D. H., & Haslam, R. J. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)94182-w · Cited by 72
Self-citationEckly, A. E., & Lugnier, C. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17009.x · Cited by 72
Baillie, G. S., MacKenzie, S. J., & Houslay, M. D. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12520-5 · Cited by 71
Abi‐Gerges, N., Ji, G. J., Lu, Z., Fischmeister, R., Hescheler, J., & Fleischmann, B. K. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.t01-2-00377.x · Cited by 70
Osinski, M., Rauch, B. H., & Schrör, K. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.1044 · Cited by 67
Palmer, D., & Maurice, D. H. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.2.247 · Cited by 64
Self-citationCyclic AMP‐mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity
Rose, R. J., liu, H., Palmer, D., et al. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701376 · Cited by 62
Self-citationYoung-Hun, C. H. O. I., Ekholm, D., Krall, J., Ahmad, F., Degerman, E., Manganiello, V. C., & Movsesian, M. A. (2000) · Biochemical Journal · doi:10.1042/bj3530041 · Cited by 54
Nitric oxide and the other cyclic nucleotide
Klein, C. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00283-2 · Cited by 50
Identification of cGMP-Dependent Protein Kinase Anchoring Proteins (GKAPs)
Vo, N., Gettemy, J. M., & Coghlan, V. M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8722 · Cited by 47
Dunkerley, H. A., Tilley, D. G., Palmer, D., Liu, H., Jimmo, S. L., & Maurice, D. H. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.5.1033 · Cited by 42
Self-citationThompson, W. J., Ashikaga, T., Kelly, J. J., et al. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00914-5 · Cited by 39
Therapeutic potential of cyclic nucleotide phosphodiesterase inhibitors in heart failure
Movsesian, M. A. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.5.963 · Cited by 37
Keravis, T. M., Komas, N. P. J., & Lugnier, C. (2000) · Journal of Vascular Research · doi:10.1159/000025738 · Cited by 33
Ashikaga, T., Strada, S. J., & Thompson, W. J. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00287-6 · Cited by 31
Netherton, S. J., Jimmo, S. L., Palmer, D., Tilley, D. G., Dunkerley, H. A., Raymond, D. R., Russell, J. C., Absher, P. M., Sage, E. H., Vernon, R. B., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1194 · Cited by 31
Self-citationJang, E. K., Davidson, M. M. L., Crankshaw, D., & Haslam, R. J. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90038-j · Cited by 18
Cited by
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
Bender, A. T., & Beavo, J. A. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.5 · Cited by 1,781
Potter, L. R., Abbey-Hosch, S., & Dickey, D. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0014 · Cited by 1,002
Pulmonary Arterial Hypertension
McLaughlin, V. V., & McGoon, M. D. (2006) · Circulation · doi:10.1161/circulationaha.104.503540 · Cited by 664
Keynote review: Phosphodiesterase-4 as a therapeutic target
Houslay, M. D., Schafer, P., & Zhang, K. Y. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03622-6 · Cited by 635
Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond
Ghofrani, H. A., Osterloh, I. H., & Grimminger, F. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2030 · Cited by 629
Metadata
- Authors
- Maurice, D. H., Palmer, D., Tilley, D. G., Dunkerley, H. A., Netherton, S. J., Raymond, D. R., Elbatarny, H. S., & Jimmo, S. L.
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2003-09
- Volume
- 64
- Issue
- 3
- Pages
- 533-546
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2147812298
- Cited by
- 322
- References
- 78
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.